Rapidly screen large numbers of samples for 17 quinolone antibiotics. Randox’
Optimised for the lowest limit of detection: below EU Maximum Residue Limits for Danofloxacin, Enrofloxacin and Marbofloxacin in milk
Intra and inter-assay precision values are 3–10%
Simple sample preparation:
Pre-coated microtitre plates and ready-to-use individual standards
2 year shelf life
Quinolones are broad-spectrum bactericidal antibiotics. They are widely used in food animal production and fish farming, as well as in human medicine. Many countries have Maximum Residue Limits for quinolones, ranging from 10 ppb for Sarafloxacin in chicken fat to 1,900 ppb for Difloxacin in poultry liver.
Foodstuffs are screened for quinolone drug residues to avoid unnecessary consumer exposure. Quinolone antibiotics can cause adverse drug reactions, also allergic reactions are relatively common. In addition, antibiotics must be used responsibly to limit the development of antibiotic resistance in human disease. This is particularly important where families of antibiotics are used both in agriculture and in human medicine.
“The misuse of antibiotics in food animals and humans results in the development of bacteria which are resistant to a range of antibiotics."
– Food Safety Authority of Ireland.
Randox produce ELISA and biochip array drug residue screening tests for antibiotics, anabolic steroids, beta-agonists, oestrogenic hormones and corticosteroids. Randox also produce biochip array technology tests for drug residue screening using the Evidence Investigator biochip imaging system. In biochip array technology, a panel of related tests are combined on a biochip and analysed simultaneously and quantatively.
Randox is an international diagnostics company, headquartered in the UK. Randox develop, manufacture and market clinical diagnostic products worldwide. Core products are: Biochip Array Technology; clinical chemistry analysers and reagents; quality controls and EQA; environmental diagnostics;
